OTCMKTS:GLAPY

Glanbia Stock Forecast, Price & News

$79.98
0.00 (0.00 %)
(As of 06/23/2021 12:00 AM ET)
Add
Compare
Today's Range
$79.98
$79.98
50-Day Range
$72.68
$79.98
52-Week Range
$48.40
$79.98
VolumeN/A
Average Volume671 shs
Market Capitalization$4.66 billion
P/E Ratio23.66
Dividend Yield1.73%
Beta0.49
30 days | 90 days | 365 days | Advanced Chart
Receive GLAPY News and Ratings via Email

Sign-up to receive the latest news and ratings for Glanbia and its competitors with MarketBeat's FREE daily newsletter.


Glanbia logo

About Glanbia

Glanbia plc operates as a nutrition company worldwide. It operates through three segments: Glanbia Performance Nutrition, Glanbia Nutritionals, and Glanbia Ireland. The Glanbia Performance Nutrition segment manufactures and sells sports nutrition and lifestyle nutrition products in various formats, including powders, ready-to-eat bars and snacking foods, and ready-to-drink beverages through various channels, such as specialty retail, e-Commerce, and gyms, as well the food, drug, mass, and club channels. The Glanbia Nutritionals segment engages in the manufacture and sale of cheese, dairy and non-dairy nutritional and functional ingredients, and vitamin and mineral premixes. The Glanbia Ireland segment produces and sells a range of value added dairy ingredients and consumer products. This segment also sells animal nutrition and fertilizer products; and operates a chain of agricultural retail outlets in Ireland. The company also engages in the financing, research and development, property and land dealing, receivables management, management, property leasing, business service, and weight management solutions businesses. It operates a portfolio of brands, including OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, ABB, think!, Amazing Grass, and BODY&FIT brands. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.

Headlines

Glanbia (OTCMKTS:GLAPY) Sets New 52-Week High at $79.98
Glanbia (OTCMKTS:GLAPY) Sets New 52-Week High at $79.98
June 21, 2021 |  americanbankingnews.com
Glanbia (OTCMKTS:GLAPY) Hits New 1-Year High at $79.98
Glanbia (OTCMKTS:GLAPY) Hits New 1-Year High at $79.98
June 15, 2021 |  americanbankingnews.com
Glanbia plc (OTCMKTS:GLAPY) Short Interest Down 75.0% in May
Glanbia plc (OTCMKTS:GLAPY) Short Interest Down 75.0% in May
June 12, 2021 |  americanbankingnews.com
Glanbia (OTCMKTS:GLAPY) Hits New 52-Week High at $79.98
Glanbia (OTCMKTS:GLAPY) Hits New 52-Week High at $79.98
June 7, 2021 |  americanbankingnews.com
Glanbia (OTCMKTS:GLAPY) Reaches New 12-Month High at $79.98
Glanbia (OTCMKTS:GLAPY) Reaches New 12-Month High at $79.98
June 1, 2021 |  americanbankingnews.com
We may test oils record lows again in mid-May: Analyst
We may test oil's record lows again in mid-May: Analyst
April 25, 2020 |  finance.yahoo.com
New Strong Sell Stocks for October 4th
New Strong Sell Stocks for October 4th
December 8, 2019 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.32 out of 5 stars

Consumer Staples Sector

118th out of 312 stocks

Private Households Industry

46th out of 381 stocks

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Glanbia (OTCMKTS:GLAPY) Frequently Asked Questions

Is Glanbia a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Glanbia in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Glanbia stock.
View analyst ratings for Glanbia
or view top-rated stocks.

What stocks does MarketBeat like better than Glanbia?

Wall Street analysts have given Glanbia a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Glanbia wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Glanbia?

Glanbia saw a decline in short interest in the month of May. As of May 28th, there was short interest totaling 100 shares, a decline of 75.0% from the May 13th total of 400 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is currently 1.0 days.
View Glanbia's Short Interest
.

How has Glanbia's stock been impacted by COVID-19 (Coronavirus)?

Glanbia's stock was trading at $57.58 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, GLAPY stock has increased by 38.9% and is now trading at $79.98.
View which stocks have been most impacted by COVID-19
.

Is Glanbia a good dividend stock?

Glanbia pays an annual dividend of $1.38 per share and currently has a dividend yield of 1.73%. The dividend payout ratio of Glanbia is 40.83%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Glanbia will have a dividend payout ratio of 29.30% next year. This indicates that Glanbia will be able to sustain or increase its dividend.
View Glanbia's dividend history.

Who are Glanbia's key executives?

Glanbia's management team includes the following people:
  • Ms. Siobhan Talbot, Group MD & Exec. Director (Age 57, Pay $2.4M)
  • Mr. Mark A. Garvey, Group Fin. Director & Exec. Director (Age 57, Pay $1.14M)
  • Mr. Brian Phelan, Chief Exec. Officer of Glanbia Nutritionals (Age 54)
  • Mr. Hugh McGuire, Chief Exec. Officer of Glanbia Performance Nutrition (Age 50)
  • Mr. Liam Hennigan, Group Director of Strategic Planning & Investor Relations
  • Ms. Martha Kavanagh, Head of Corp. Communications
  • Mr. Tom Tench, Group Corp. Devel. Director (Age 50)
  • Mr. Michael Patten, Director of Group HR & Corp. Affairs (Age 59)
  • Mr. Michael Horan, Company Sec. (Age 56)
  • Mr. Jim Bergin, Chief Exec. of Glanbia Ingredients Ireland Limited (Age 58)

Who are some of Glanbia's key competitors?

What is Glanbia's stock symbol?

Glanbia trades on the OTCMKTS under the ticker symbol "GLAPY."

How do I buy shares of Glanbia?

Shares of GLAPY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Glanbia's stock price today?

One share of GLAPY stock can currently be purchased for approximately $79.98.

How much money does Glanbia make?

Glanbia has a market capitalization of $4.66 billion and generates $4.37 billion in revenue each year. The company earns $164.26 million in net income (profit) each year or $3.38 on an earnings per share basis.

How many employees does Glanbia have?

Glanbia employs 7,385 workers across the globe.

What is Glanbia's official website?

The official website for Glanbia is www.glanbia.com.

Where are Glanbia's headquarters?

Glanbia is headquartered at Glanbia House Ring Road, KILKENNY L2, R95 E866.

How can I contact Glanbia?

Glanbia's mailing address is Glanbia House Ring Road, KILKENNY L2, R95 E866. The company can be reached via phone at 353-56-777-2200 or via email at [email protected]


This page was last updated on 6/24/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.